Goodwill of Summit Therapeutics Inc. from 31 Jan 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Summit Therapeutics Inc. quarterly Goodwill in USD history and change rate from 31 Jan 2017 to 30 Sep 2025.
  • Summit Therapeutics Inc. Goodwill for the quarter ending 30 Sep 2025 was $1,999,000, a 0.4% increase year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

Summit Therapeutics Inc. Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,999,000 +$8,000 +0.4% 30 Sep 2025 10-Q 20 Oct 2025 2025 Q3
Q2 2025 $2,039,000 +$159,000 +8.5% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $1,923,000 +$48,000 +2.6% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $1,864,000 -$29,000 -1.5% 31 Dec 2024 10-Q 20 Oct 2025 2025 Q3
Q3 2024 $1,991,000 +$177,000 +9.8% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 $1,880,000 -$3,000 -0.16% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $1,875,000 +$36,000 +2% 31 Mar 2024 10-Q 01 May 2024 2024 Q1
Q4 2023 $1,893,000 +$95,000 +5.3% 31 Dec 2023 10-K 24 Feb 2025 2024 FY
Q3 2023 $1,814,000 +$159,000 +9.6% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $1,883,000 +$77,000 +4.3% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $1,839,000 -$114,000 -5.8% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $1,798,000 -$211,000 -11% 31 Dec 2022 10-K 20 Feb 2024 2023 FY
Q3 2022 $1,655,000 -$346,000 -17% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $1,806,000 -$251,000 -12% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $1,953,000 -$94,000 -4.6% 31 Mar 2022 10-Q 11 May 2022 2022 Q1
Q4 2021 $2,009,000 -$21,000 -1% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 $2,001,000 -$334,000 -14% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $2,057,000 -$179,000 -8% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $2,047,000 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 $2,030,000 +$69,000 +3.5% 31 Dec 2020 10-K/A 21 Dec 2022 2021 FY
Q3 2020 $2,335,000 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 $2,236,000 30 Jun 2020 8-K 29 Sep 2020 2020 Q2
Q4 2019 $1,961,000 +$10,000 +0.51% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q4 2018 $1,951,000 -$1,562,000 -44% 31 Jan 2019 10-K 31 Mar 2021 2020 FY
Q4 2017 $3,513,000 +$2,677,000 +320% 31 Jan 2018 8-K 29 Sep 2020 2020 Q2
Q4 2016 $836,000 31 Jan 2017 8-K 29 Sep 2020 2020 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.